Clinical Trial Update: Efficacy of Guselkumab in Treating Hailey Hailey Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Yale University is evaluating the efficacy of guselkumab for Hailey-Hailey disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hailey-hailey Disease

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Yale University | Conditions: Hailey Hailey Disease | Phase 2 | Status: RECRUITING